WCN26-3141 SERUM 1,25-DIHYDROXYVITAMIN D LEVELS AND POOR KIDNEY OUTCOMES

Read full text Summarise with VIRAT
Authors: Kohei Ohori, Masahiro Eriguchi, Takaaki Kosugi, Wasako Tato, Yasuto Shoji, Hiroyuki Tamaki, Riri Furuyama, Takayuki Uemura, Hikari Tasaki, Masatoshi Nishimoto, Kaori Tanabe, Keisuke Okamoto
+3 more Masaru Matsui, Ken‐ichi Samejima, Kazuhiko Tsuruya
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Low serum 25-hydroxyvitamin D levels, which reflect the body’s vitamin D stores, have been reported to be associated with poor kidney outcomes. In contrast, serum 1,25-dihydroxyvitamin D [1,25(OH)2D], the biologically active form of vitamin D rather than nutritional stores, has been less well studied, and its association with kidney prognosis remains limited. We aimed to investigate the association between baseline serum 1,25(OH)2D levels and kidney function decline in a prospective cohort study.

Fields of Study & Subjects

Vitamin D Research Studies Chronic Kidney Disease and Diabetes Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104314–104314
Publication date
25 March 2026
Language
EN